@ARTICLE{
author={Belancic Andrej,Jankovic Slobodan,Vitezic Dinko},
year={2026},
title={Pharmacoeconomics and outcomes research: Redefining value in the era of therapeutic innovation-Editorial},
journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
volume={},
number={},
pages={-},
document_type={Editorial Material; Early Access},
} 

@ARTICLE{
author={Sener Yusuf Ziya,Mancusi Costantino,Ceasovschih Alexandr,Belancic Andrej,Menti Ariadni,Antza Christina,Ferrao Diana,Petrovic Jelena M,Huart Justine,Labr Karel,Fucile Ilaria,Vuckovic Marijana,Porcnik Andrej,Sinigoj Petra,Katsiki Niki},
year={2026},
title={Interventional Treatment of Arterial Hypertension in The Modern Era: An Updated Review from the Young Investigator Group of the European Society of Hypertension},
journal={HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION},
volume={},
number={},
pages={-},
document_type={Review; Early Access},
} 

@ARTICLE{
author={Jankovic Slobodan M,Milosavljevic Milos N,Stevic Ivana,Asic Adna,Jusic Amela,Devaux Yvan,Belancic Andrej,Bektay Muhammed Yunus,Pejcic Ana V},
year={2026},
title={Cost-Effectiveness of Pharmacogenomics-Guided Treatment in Cardiovascular Disease: An Umbrella Review},
journal={PHARMACOGENOMICS & PERSONALIZED MEDICINE},
volume={19},
number={},
pages={-},
document_type={Review},
} 

@ARTICLE{
author={Gkrinia Elvira Meni Maria,Belancic Andrej,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M},
year={2026},
title={Pharmacoeconomics of high-cost therapies: real world challenges},
journal={EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH},
volume={},
number={},
pages={-},
document_type={Review; Early Access},
} 

@ARTICLE{
author={Belancic Andrej,Gkrinia Elvira Meni Maria,Sel Eda Kubra,Roncato Rossana,Jankovic Slobodan M,Vitezic Dinko},
year={2026},
title={A systematic literature review of economic evaluations of setmelanotide},
journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
volume={82},
number={5},
pages={-},
document_type={Review},
} 

@ARTICLE{
author={Gkrinia Elvira Meni Maria,Belancic Andrej,Jankovic Slobodan M},
year={2026},
title={Putting FAERS data into perspective: cautionary considerations for comparative safety assessment},
journal={EUROPEAN JOURNAL OF HOSPITAL PHARMACY},
volume={},
number={},
pages={-},
document_type={Editorial Material; Early Access},
} 

@ARTICLE{
author={Belancic Andrej,Fajkic Almir,Wah Lam Yun,Alic Lejla,Labriffe Marc,Pilipovic Kristina,Dzidic-Krivic Amina,Yee Sy Hing,Jankovic Slobodan M},
year={2026},
title={Microbiome-driven PKs: addressing research gaps and shaping future directions beyond the narrative review},
journal={EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY},
volume={},
number={},
pages={-},
document_type={Editorial Material; Early Access},
} 

@ARTICLE{
author={Belancic Andrej,Jankovic Slobodan M},
year={2026},
title={Pharmacoeconomic digital twins: A visionary framework for the future of precision pharmacology},
journal={HEALTH POLICY AND TECHNOLOGY},
volume={15},
number={4},
pages={-},
document_type={Editorial Material},
} 

@ARTICLE{
author={Belancic Andrej,Eustaquio Patrick,Gkrinia Elvira Meni Maria,Stevic Ivana,Javor Eugen,Lam Yun Wah,Jankovic Slobodan M,Vitezic Dinko},
year={2026},
title={The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovations},
journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
volume={},
number={},
pages={-},
document_type={Review; Early Access},
} 

@ARTICLE{
author={Belancic Andrej,Fajkic Almir,Wah Lam Yun,Alic Lejla,Labriffe Marc,Pilipovic Kristina,Dzidic-Krivic Amina,Yee Sy Hing,Jankovic Slobodan M},
year={2026},
title={Microbiome-driven PKs: redefining drug metabolism beyond host enzymes},
journal={EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY},
volume={},
number={},
pages={-},
document_type={Review; Early Access},
} 

@ARTICLE{
author={Belancic Andrej,Litonius Kaisa,Kulla Noora,Likic Robert,Jankovic Slobodan M,Vitezic Dinko,Backman Janne T},
year={2025},
title={Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology},
journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
volume={82},
number={1},
pages={-},
document_type={Letter},
} 

@ARTICLE{
author={Belancic Andrej,Stevic Ivana,Gkrinia Elvira Meni Maria,Vitezic Dinko,Jankovic Slobodan M},
year={2025},
title={Cost-utility analysis of nusinersen-risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model},
journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={Sel Eda Kubra,Gkrinia Elvira Meni Maria,Roncato Rossana,Vitezic Dinko,Jankovic Slobodan M,Belancic Andrej},
year={2025},
title={Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence},
journal={JOURNAL OF INTERNATIONAL MEDICAL RESEARCH},
volume={53},
number={11},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Belancic Andrej,Mas Petar,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M},
year={2025},
title={Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union},
journal={NEUROLOGY INTERNATIONAL},
volume={17},
number={10},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Belancic Andrej,Raicevic Branislava B,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M},
year={2025},
title={Costs of Treating Onasemnogene Abeparvovec-Xioi-Induced Liver Injury},
journal={PHARMACOLOGY RESEARCH & PERSPECTIVES},
volume={13},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Raicevic Branislava B,Belancic Andrej,Mirkovic Nikola F,Jankovic Slobodan M},
year={2025},
title={Analysis of Reporting Trends of Serious Adverse Events Associated With Anti-Obesity Drugs},
journal={PHARMACOLOGY RESEARCH & PERSPECTIVES},
volume={13},
number={2},
pages={-},
document_type={Article},
}